Physicians' Academy for Cardiovascular Education

Understanding Diabetic Kidney Disease: What are the best options for clinical management?

July 30, 2016 - Asian Interchange on Diabetes meeting - Per-Henrik Groop, MD – University of Helsinki, Helsinki, Finland

Dr. Per-Henrik Groop outlines that diabetic kidney disease is common and associated with a grim prognosis. Optimal glucose control is central to limiting the risk of renal complications. Newer antidiabetic drugs can play a welcome role to optimally treat these patients.

This lecture was recorded during the Asian Interchange on Diabetes meeting, held in Bangkok on July 30-31, 2016

Video navigation menu

  • Kidney disease in diabetes greatly enhances risk of CV morbidity and mortality 1:52
  • Importance of blood glucose control - a five finger rule to optimally treat diabetic kidney disease 8:22
  • Achieving glucose control without causing harm - DPP4 inhibitors and GLP-1 agonists and renal function 12:21
  • Pre-specified renal endpoints with SGLT2 inhibition in the EMPA-REG OUTCOME trial 20:03
  • Implications of the renal results of empagliflozin 22:34
  • Why does empagliflozin work so well and how can we benefit from it in clinical practice? 24:00